The emerging role of long non-coding RNAs in schizophrenia.

Front Psychiatry

Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder, First Hospital of Shanxi Medical University, Taiyuan, China.

Published: September 2022

Schizophrenia (SZ) is a severe psychiatric disorder which is contributed by both genetic and environmental factors. However, at present, its specific pathogenesis is still not very clear, and there is a lack of objective and reliable biomarkers. Accumulating evidence indicates that long non-coding RNAs (lncRNAs) are involved in the pathophysiology of several psychiatric disorders, including SZ, and hold promise as potential biomarkers and therapeutic targets for psychiatric disorders. In this review, we summarize and discuss the role of lncRNAs in the pathogenesis of SZ and their potential value as biomarkers and therapeutic targets.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548578PMC
http://dx.doi.org/10.3389/fpsyt.2022.995956DOI Listing

Publication Analysis

Top Keywords

long non-coding
8
non-coding rnas
8
psychiatric disorders
8
potential biomarkers
8
biomarkers therapeutic
8
therapeutic targets
8
emerging role
4
role long
4
rnas schizophrenia
4
schizophrenia schizophrenia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!